series-b
Stage
1
Investors
About
iVexSol Technologies develops lentiviral vector technology to supply consistent sources of vectors for successful gene therapy programs. Their technology produces delivery vehicles critical for manufacturing life-changing cell and gene therapies, enabling physicians to treat later-stage cancers and rare genetic disorders.
Explore iVexSol Technologies's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.